TYME stock forecast
Our latest prediction for Tyme Technologies Inc's stock price was made on the Nov. 3, 2021 when the stock price was at 1.01$.
In the short term (2weeks), TYME's stock price should outperform the market by 4.49%. During that period the price should oscillate between -10.77% and +15.38%.
In the medium term (3months), TYME's stock price should outperform the market by 30.27%. During that period the price should oscillate between -36.70% and +45.51%.
Get email alertsCreate a solid portfolio with TYME
About Tyme Technologies Inc
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.17$ per share.
The book value per share is 0.22$
Three months stock forecastNov. 3, 2021
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -25M | - | -25M | -0.17 | - | - | 157M | 0.22 | -21M | - | -21M |